Evidence-Based Complementary and Alternative Medicine
Recently Published Articles | |
Research Progress and Treatment Status of Liver Cirrhosis with Hypoproteinemia, Jianxia Wen, Xing Chen, Shizhang Wei, Xiao Ma, and Yanling Zhao Volume 2022 (2022), Article ID 2245491, 8 pages | |
Protective Effects of Alternanthera sessilis Ethanolic Extract against TNF-α or H2O2-Induced Endothelial Activation in Human Aortic Endothelial Cells, Nur Nadia Mohd Razali, Soek Sin Teh, Siau Hui Mah, Yoke Keong Yong, Chin Theng Ng, Yang Mooi Lim, and Lai Yen Fong Volume 2022 (2022), Article ID 8738435, 12 pages | |
Molecular Mechanism Investigation on Monomer Kaempferol of the Traditional Medicine Dingqing Tablet in Promoting Apoptosis of Acute Myeloid Leukemia HL-60 Cells, Dandan Zheng, Yongming Zhou, Yong Liu, Lihai Ma, and Lingzhan Meng Volume 2022 (2022), Article ID 8383315, 11 pages | |
Neurodoron® for Stress Impairments: A Prospective, Multicenter Non-Interventional Trial, Juliane Hellhammer, Katja Schmidt, Cristina Semaca, and Rebecca Hufnagel Volume 2022 (2022), Article ID 2626645, 11 pages | |
Resveratrol Inhibits High Glucose-Induced H9c2 Cardiomyocyte Hypertrophy and Damage via RAGE-Dependent Inhibition of the NF-κB and TGF-β1/Smad3 Pathways, Yanzhou Zhu, Fuling Wu, Qin Yang, Haixing Feng, and Dingli Xu Volume 2022 (2022), Article ID 7781910, 10 pages | |
An Algorithm for Automatic Rib Fracture Recognition Combined with nnU-Net and DenseNet, Junzhong Zhang, Zhiwei Li, Shixing Yan, Hui Cao, Jing Liu, and Dejian Wei Volume 2022 (2022), Article ID 5841451, 9 pages | |
Effect of Acupoint Catgut Embedding for Middle-Aged Obesity: A Multicentre, Randomised, Sham-Controlled Trial, Xia Chen, Wei Huang, Dan Wei, Ji-Ping Zhao, Wei Zhang, De-Guang Ding, Yang Jiao, Hong-Ling Pan, Jia-Jia Zhang, Feng Zhong, Feng Gao, Yi-Ting Jin, Yi-Wei Zheng, Yan-Ji Zhang, Qiao Huang, Xian-Tao Zeng, and Zhong-Yu Zhou Volume 2022 (2022), Article ID 4780019, 19 pages | |
Emodin Alleviates High-Glucose-Induced Pancreatic β-Cell Pyroptosis by Inhibiting NLRP3/GSDMD Signaling, Yiqian Xing, Yuchi He, Yuan Zhang, Heting Wang, Sihan Peng, Chunguang Xie, Jian Kang, Ya Liu, and Xiyu Zhang Volume 2022 (2022), Article ID 5276832, 10 pages | |
miR-96-5p Induces Orbital Fibroblasts Differentiation by Targeting Smad7 and Promotes the Development of Thyroid-Associated Ophthalmopathy, Jianshu Kang, Yunqin Li, Yue Zou, Zhijian Zhao, Linan Jiao, and Hong Zhang Volume 2022 (2022), Article ID 8550307, 11 pages | |
The Role of PKC and HIF-1 and the Effect of Traditional Chinese Medicinal Compounds on Cerebral Ischemia-Reperfusion Injury, Zheyu Fang, Yangyang Zhang, Xixi Zhao, Weifeng Jin, and Li Yu Volume 2022 (2022), Article ID 1835898, 12 pages | |
Mechanism of Huoluo Xiaoling Dan in the Treatment of Psoriasis Based on Network Pharmacology and Molecular Docking, Ke Gong, Wen Guo, Kaiqing Du, Fang Wang, Mengli Li, and Jianhui Guo Volume 2022 (2022), Article ID 7053613, 12 pages | |
Exploring the Mechanism of Astragalus propinquus Schischkin and Panax Notoginseng (A&P) Compounds in the Treatment of Renal Fibrosis and Chronic Kidney Disease Based on Integrated Network Analysis, Wang Xiaojia, Li Jianchun, Zhu Bingwen, He Xingcan, Deng Yanmei, and Wang Li Volume 2022 (2022), Article ID 2646022, 13 pages | |
Using Network Pharmacology to Systematically Decipher the Potential Mechanisms of Jisuikang in the Treatment of Spinal Cord Injury, Shaoshuo Li, Yang Shao, Hao Chen, and Jianwei Wang Volume 2022 (2022), Article ID 4932153, 14 pages | |
| |
Best regards, The Evidence-Based Complementary and Alternative Medicine team ecam@hindawi.com | |
Hindawi Limited, Adam House, Third Floor |
You have received this email to evidencehub.evidencehub@blogger.com from Evidence-Based Complementary and Alternative Medicine (published by Hindawi Limited, company number: 08671628, with registered address: Adam House, Third Floor, 1 Fitzroy Square, London, W1T 5HF, UK) because you have actively signed up to receive content alerts from Evidence-Based Complementary and Alternative Medicine. Hindawi respects your right to privacy and will not disclose your email address to any third parties without your consent. To see the types of information we may hold or collect about you and how we may use that information, please see our Privacy Policy. If you would prefer not to receive any further messages from Evidence-Based Complementary and Alternative Medicine or Hindawi, please contact Privacy@hindawi.com or click here to unsubscribe from the alert mailing list.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home